KMPH KMPH

KemPharm Stock Price

4.67
0.07 (1.52%)
Upgrade to Real-Time
Afterhours (Closed)
4.67
Volume 224,825
Bid Price 4.67
Ask Price 5.15
News -
Day High 4.73

Low
4.00

52 Week Range

High
15.6967

Day Low 4.47
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
KemPharm Inc KMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 1.52% 4.67 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.60 4.47 4.73 4.69 4.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,839 224,825 $ 4.62 $ 1,038,229 - 4.00 - 15.6967
Last Trade Time Type Quantity Stock Price Currency
17:59:53 formt 175 $ 4.67 USD

Period:

Draw Mode:

KemPharm Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 160.76M 34.42M 34.24M $ 28.65M $ -696.20k -2.90 -9.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 611.51k 0.80%

more financials information »

KemPharm News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical KMPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.155.174.324.71375,477-0.48-9.32%
1 Month4.325.22994.004.49533,1290.358.1%
3 Months5.375.734.004.77542,423-0.70-13.04%
6 Months8.119.42994.006.06516,859-3.44-42.42%
1 Year9.8515.69674.008.92558,133-5.18-52.59%
3 Years1.6918.150.185.811,244,6432.98176.33%
5 Years4.3018.150.185.63746,3360.378.6%

KemPharm Description

KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of treatments for the central nervous system, CNS, and rare disease indications. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety.


Your Recent History
NASDAQ
KMPH
KemPharm
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.